Ischemic stroke in cancer patients with and without conventional mechanisms: A multicenter study in Korea

Stroke

Volumn 41, Issue 4, 2010, Pages 798-801

  Kim, Seon Gyeong ^a   Hong, Ji Man ^b   Kim, Hahn Young ^c   Lee, Jun ^d   Chung, Pil Wook ^e   Park, Kwang Yeol ^f   Kim, Gyeong Moon ^a   Lee, Kwang Ho ^a   Chung, Chin Sang ^a   Bang, Oh Young ^a  

^a Sungkyunkwan University   (South Korea)

^b Ajou University Medical CentSuwon   (South Korea)

^c Konkuk University Hospital   (South Korea)

^d Young Nam University Hospital   (South Korea)

^e School of Medicine   (South Korea)

^f Chung Ang University College of Medicine   (South Korea)

Author keywords

Cancer; Hypercoagulopathy; Ischemic stroke; Magnetic resonance imaging

Indexed keywords

D DIMER;

ADULT; AGE DISTRIBUTION; AGED; ARTERY LESION; ARTICLE; BLOOD CLOTTING DISORDER; CANCER PATIENT; CEREBROVASCULAR ACCIDENT; COLORECTAL CANCER; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SOUTH KOREA; STOMACH CANCER; STROKE;

AGED; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; REGISTRIES; REPUBLIC OF KOREA; RISK FACTORS; STROKE;

EID: 77950225519     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.571356     Document Type: Article

References (11)

1. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore). 1985;64:16-35.
2. Rogers LR. Cerebrovascular complications in patients with cancer. Semin Neurol. 2004;24:453-460.
3. Grisold W, Oberndorfer S, Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009;119:1-16.
4. Bick RL. Cancer-associated thrombosis. N Engl J Med. 2003;349: 109-111.
5. Chaturvedi S, Ansell J, Recht L. Should cerebral ischemic events in cancer patients be considered a manifestation of hypercoagulability? Stroke. 1994;25:1215-1218.
6. Zhang YY, Chan DK, Cordato D, Shen Q, Sheng AZ. Stroke risk factor, pattern and outcome in patients with cancer. Acta Neurol Scand. 2006; 114:378-383.
7. Zhang YY, Cordato D, Shen Q, Sheng AZ, Hung WT, Chan DK. Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study. Cerebrovasc Dis. 2007;23:181-187.
8. Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62: 2025-2030.
9. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous throm-boembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
10. Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, van Dam P, Prove A, Lemmens J, Vermeulen P. Plasma fibrin d-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86:389-395.
11. Kwon HM, Kang BS, Yoon BW. Stroke as the first manifestation of concealed cancer. J Neurol Sci. 2007;258:80-83.